Cemiplimab, a human PD-1 monoclonal antibody, in patients (pts) with recurrent or metastatic cervical cancer: Interim data from phase I cohorts

D. Rischin, M. Gil-Martin, A. González-Martín, I. Brana, J. Y. Hou, D. Cho, G. S. Falchook, S. Formenti, S. Jabbour, K. Moore, A. Naing, K. P. Papadopoulos, J. Baranda, A. Weise, M. G. Fury, M. Feng, J. Li, I. Lowy, M. Mathias

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)viii342-viii343
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
StatePublished - Oct 1 2018
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this